Is IMUX undervalued or overvalued?
As of 2025-03-15, the Intrinsic Value of Immunic Inc (IMUX) is -5.38 USD. This IMUX valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.15 USD, the upside of Immunic Inc is -567.72%. This means that IMUX is overvalued by 567.72%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -5.38 - -5.38 | -5.38 | -567.72% |
| P/E | (7.10) - (7.77) | (7.85) | -782.9% |
| DDM - Stable | (6.63) - (18.67) | (12.65) | -1200.1% |
| DDM - Multi | (2.40) - (5.35) | (3.32) | -388.8% |
| Market Cap (mil) | 103.59 |
| Beta | 1.59 |
| Outstanding shares (mil) | 90.08 |
| Enterprise Value (mil) | 44.52 |
| Market risk premium | 4.60% |
| Cost of Equity | 12.27% |
| Cost of Debt | 5.00% |
| WACC | 7.97% |